August 12, 2015 / 5:37 AM / 2 years ago

BRIEF-Cytos Biotechnology exclusively licenses its VLP platform for treatment of cancer to Checkmate Pharmaceuticals Llc

Aug 12 (Reuters) - Cytos Biotechnology AG :

* Cytos Biotechnology Ltd exclusively licenses its VLP platform for the treatment of cancer to Checkmate Pharmaceuticals Llc

* Cytos may receive up to $90 million in development milestones and may receive up to double-digit royalties on net sales from successfully developed products Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below